김형준 (한국뇌연구원)님 | 한빛사연구자 > 한빛사

한국뇌연구원

최종업데이트 2022.04.01.

Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models
- Dev. Cell, Volume 57, Issue 6, 28 March 2022, Pages 783-798.e8 | https://doi.org/10.1016/j.devcel.2022.02.022
- 2022-03
- 생명과학
- 한빛사논문
PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies
- Autophagy, Published online: 05 Nov 2019 | https://doi.org/10.1080/15548627.2019.1686729
- 2019-11
- 생명과학
- 한빛사논문
- 김형준(University of Pennsylvania, 현 한국뇌연구원)
  Interview
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models
- Nat. Genet., 46, 152-160 (2014). Published online 15 December 2013 | doi:10.1038/ng.2853
- 2013-12
- 생명과학
- 한빛사논문, 상위피인용논문
- 김형준(University of Pennsylvania)
  Interview
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
- Nature, 466, 1069–1075 (26 August 2010) | doi:10.1038/nature09320
- 2010-08
- 생명과학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문